Cargando…

The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial

OBJECTIVES: Silver fibre gloves transport heat from the palm to the fingers, possibly reducing the burden of RP in SSc patients. We aim to evaluate the clinical efficiency of this intervention. METHODS: A multicentre, double-blind, randomized trial was performed, accounting for interindividual diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liem, Sophie I E, Hoekstra, Eva M, Bonte-Mineur, Femke, Magro Checa, César, Schouffoer, Anne, Allaart, Cornelia F, Huizinga, Tom W J, Bergstra, Sytske Anne, de Vries-Bouwstra, Jeska K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910564/
https://www.ncbi.nlm.nih.gov/pubmed/35441683
http://dx.doi.org/10.1093/rheumatology/keac243
_version_ 1784884809636511744
author Liem, Sophie I E
Hoekstra, Eva M
Bonte-Mineur, Femke
Magro Checa, César
Schouffoer, Anne
Allaart, Cornelia F
Huizinga, Tom W J
Bergstra, Sytske Anne
de Vries-Bouwstra, Jeska K
author_facet Liem, Sophie I E
Hoekstra, Eva M
Bonte-Mineur, Femke
Magro Checa, César
Schouffoer, Anne
Allaart, Cornelia F
Huizinga, Tom W J
Bergstra, Sytske Anne
de Vries-Bouwstra, Jeska K
author_sort Liem, Sophie I E
collection PubMed
description OBJECTIVES: Silver fibre gloves transport heat from the palm to the fingers, possibly reducing the burden of RP in SSc patients. We aim to evaluate the clinical efficiency of this intervention. METHODS: A multicentre, double-blind, randomized trial was performed, accounting for interindividual differences and external factors using a crossover design. Patients were randomized in two groups: group 1 wore 8% silver fibre gloves in period 1 and normal gloves in period 2 and group 2 vice versa. Each period lasted 6 weeks. The primary outcome was the Raynaud Condition Score (RCS) over time (minimal clinical important difference 1.4), assessed three times per week using an online questionnaire. Secondary outcomes included vascular complications and Scleroderma-Health Assessment Questionnaire (SHAQ). Outcomes were evaluated before unblinding using linear mixed models. RESULTS: A total of 85 SSc patients were included, with 76 completing the study. The mean RCS during 2 weeks before the study (i.e. without gloves) was 6.4 (s.d. 1.6). Both with silver fibre gloves and normal gloves the mean RCS decreased to 3.9 (s.d. 2.3) with a similar course over time. There was no difference in mean RCS over time between the type of gloves [β = 0.067 (95% CI −0.006, 0.19)]. Of secondary outcomes, total SHAQ [β = 0.036 (95% CI 0.026, 0.046)] was slightly higher with silver fibre gloves, which is clinically irrelevant. Three patients developed new digital ulcers with normal gloves vs one patient with silver fibre gloves [odds ratio 3.2 (95% CI 0.32, 31.1)]. CONCLUSIONS: Wearing gloves in SSc patients clearly decreases the RP burden. Our results do not support the hypothesis that increased heat transport of 8% silver fibre gloves is associated with less disease burden as measured in this study by the RCS compared with normal gloves. CLINICAL TRIAL REGISTRATION NUMBER: Netherlands Trial register (https://www.trialregister.nl/) NL7904
format Online
Article
Text
id pubmed-9910564
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-99105642023-02-13 The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial Liem, Sophie I E Hoekstra, Eva M Bonte-Mineur, Femke Magro Checa, César Schouffoer, Anne Allaart, Cornelia F Huizinga, Tom W J Bergstra, Sytske Anne de Vries-Bouwstra, Jeska K Rheumatology (Oxford) Clinical Science OBJECTIVES: Silver fibre gloves transport heat from the palm to the fingers, possibly reducing the burden of RP in SSc patients. We aim to evaluate the clinical efficiency of this intervention. METHODS: A multicentre, double-blind, randomized trial was performed, accounting for interindividual differences and external factors using a crossover design. Patients were randomized in two groups: group 1 wore 8% silver fibre gloves in period 1 and normal gloves in period 2 and group 2 vice versa. Each period lasted 6 weeks. The primary outcome was the Raynaud Condition Score (RCS) over time (minimal clinical important difference 1.4), assessed three times per week using an online questionnaire. Secondary outcomes included vascular complications and Scleroderma-Health Assessment Questionnaire (SHAQ). Outcomes were evaluated before unblinding using linear mixed models. RESULTS: A total of 85 SSc patients were included, with 76 completing the study. The mean RCS during 2 weeks before the study (i.e. without gloves) was 6.4 (s.d. 1.6). Both with silver fibre gloves and normal gloves the mean RCS decreased to 3.9 (s.d. 2.3) with a similar course over time. There was no difference in mean RCS over time between the type of gloves [β = 0.067 (95% CI −0.006, 0.19)]. Of secondary outcomes, total SHAQ [β = 0.036 (95% CI 0.026, 0.046)] was slightly higher with silver fibre gloves, which is clinically irrelevant. Three patients developed new digital ulcers with normal gloves vs one patient with silver fibre gloves [odds ratio 3.2 (95% CI 0.32, 31.1)]. CONCLUSIONS: Wearing gloves in SSc patients clearly decreases the RP burden. Our results do not support the hypothesis that increased heat transport of 8% silver fibre gloves is associated with less disease burden as measured in this study by the RCS compared with normal gloves. CLINICAL TRIAL REGISTRATION NUMBER: Netherlands Trial register (https://www.trialregister.nl/) NL7904 Oxford University Press 2022-04-20 /pmc/articles/PMC9910564/ /pubmed/35441683 http://dx.doi.org/10.1093/rheumatology/keac243 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Science
Liem, Sophie I E
Hoekstra, Eva M
Bonte-Mineur, Femke
Magro Checa, César
Schouffoer, Anne
Allaart, Cornelia F
Huizinga, Tom W J
Bergstra, Sytske Anne
de Vries-Bouwstra, Jeska K
The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
title The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
title_full The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
title_fullStr The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
title_full_unstemmed The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
title_short The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
title_sort effect of silver fibre gloves on raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910564/
https://www.ncbi.nlm.nih.gov/pubmed/35441683
http://dx.doi.org/10.1093/rheumatology/keac243
work_keys_str_mv AT liemsophieie theeffectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT hoekstraevam theeffectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT bontemineurfemke theeffectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT magrochecacesar theeffectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT schouffoeranne theeffectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT allaartcorneliaf theeffectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT huizingatomwj theeffectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT bergstrasytskeanne theeffectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT devriesbouwstrajeskak theeffectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT liemsophieie effectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT hoekstraevam effectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT bontemineurfemke effectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT magrochecacesar effectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT schouffoeranne effectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT allaartcorneliaf effectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT huizingatomwj effectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT bergstrasytskeanne effectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial
AT devriesbouwstrajeskak effectofsilverfibreglovesonraynaudsphenomenoninpatientswithsystemicsclerosisadoubleblindrandomizedcrossovertrial